Published in Hum Mol Genet on November 26, 2009
Transcription factor pathways and congenital heart disease. Curr Top Dev Biol (2012) 1.41
Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data. Circ Res (2014) 1.32
Partitioning the heart: mechanisms of cardiac septation and valve development. Development (2012) 1.13
Dynamic and differential regulation of stem cell factor FoxD3 in the neural crest is Encrypted in the genome. PLoS Genet (2012) 1.04
Genetic basis of congenital cardiovascular malformations. Eur J Med Genet (2014) 1.00
The molecular genetics of congenital heart disease: a review of recent developments. Curr Opin Cardiol (2010) 0.96
ETS-dependent regulation of a distal Gata4 cardiac enhancer. Dev Biol (2011) 0.95
Identification and dissection of a key enhancer mediating cranial neural crest specific expression of transcription factor, Ets-1. Dev Biol (2013) 0.91
New Genetic Insights into Congenital Heart Disease. J Clin Exp Cardiolog (2012) 0.89
Genetics and Genomics of Congenital Heart Disease. Circ Res (2017) 0.81
Probing human cardiovascular congenital disease using transgenic mouse models. Prog Mol Biol Transl Sci (2011) 0.81
Distal Deletion of Chromosome 11q Encompassing Jacobsen Syndrome without Platelet Abnormality. Clin Med Insights Pediatr (2014) 0.81
Multiplex ligation-dependent probe amplification and array comparative genomic hybridization analyses for prenatal diagnosis of cytogenomic abnormalities. Mol Cytogenet (2014) 0.80
De Novo ring chromosome 11 and non-reciprocal translocation of 11p15.3-pter to 21qter in a patient with congenital heart disease. Mol Cytogenet (2015) 0.79
MatrixCatch--a novel tool for the recognition of composite regulatory elements in promoters. BMC Bioinformatics (2013) 0.79
Cytogenomic Aberrations in Congenital Cardiovascular Malformations. Mol Syndromol (2016) 0.79
PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking. Nat Commun (2016) 0.76
Mutational screening of affected cardiac tissues and peripheral blood cells identified novel somatic mutations in GATA4 in patients with ventricular septal defect. J Biomed Res (2011) 0.76
Rac1 signaling is critical to cardiomyocyte polarity and embryonic heart development. J Am Heart Assoc (2014) 0.76
microRNA expression profiling and functional annotation analysis of their targets modulated by oxidative stress during embryonic heart development in diabetic mice. Reprod Toxicol (2016) 0.75
The transcription factors Ets1 and Sox10 interact during murine melanocyte development. Dev Biol (2015) 0.75
Elucidating the mechanisms of transcription regulation during heart development by next-generation sequencing. J Hum Genet (2015) 0.75
The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency. J Clin Immunol (2015) 0.75
Rare copy number variants in patients with congenital conotruncal heart defects. Birth Defects Res (2017) 0.75
Jacobsen Syndrome: Surgical Complications due to Unsuspected Diagnosis, the Importance of Molecular Studies in Patients with Craniosynostosis. Mol Syndromol (2015) 0.75
Assessment of large copy number variants in patients with apparently isolated congenital left-sided cardiac lesions reveals clinically relevant genomic events. Am J Med Genet A (2017) 0.75
Fate of the mammalian cardiac neural crest. Development (2000) 6.79
Molecular biology of the Ets family of transcription factors. Gene (2003) 4.41
Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet (1996) 3.71
Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol (2000) 2.69
The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity (1998) 2.68
Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity (2000) 2.59
Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature (1995) 2.46
Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature (1995) 2.33
Abnormal heart rate regulation in GIRK4 knockout mice. Neuron (1998) 2.27
FGF signaling delineates the cardiac progenitor field in the simple chordate, Ciona intestinalis. Genes Dev (2006) 2.22
An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation. J Clin Invest (2007) 2.09
Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol (2004) 1.89
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest (2005) 1.89
Mouse models in the study of the Ets family of transcription factors. Oncogene (2000) 1.84
An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev (2002) 1.73
The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A (2004) 1.65
An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. Hum Hered (1973) 1.64
Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct (2001) 1.48
Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol (2005) 1.41
Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech Dev (2001) 1.39
Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene (1994) 1.33
pannier and pointedP2 act sequentially to regulate Drosophila heart development. Development (2003) 1.29
Clinical and molecular characterization of patients with distal 11q deletions. Am J Hum Genet (1995) 1.17
Pinch1 is required for normal development of cranial and cardiac neural crest-derived structures. Circ Res (2007) 1.15
Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos. Circ Res (2003) 1.12
Role of the Rho GTPase-activating protein RICS in neurite outgrowth. Genes Cells (2006) 1.08
The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus. Proc Natl Acad Sci U S A (2004) 1.08
Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis. Genomics (2002) 1.02
A 5.5-kb enhancer is both necessary and sufficient for regulation of Wnt-1 transcription in vivo. Dev Biol (1997) 1.00
The Ets-transcription factor family in embryonic development: lessons from the amphibian and bird. Oncogene (2000) 0.98
Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome). Neurogenetics (2008) 0.98
Variations in microscopic anatomy and ultrastructure of human embryonic hearts subjected to three different modes of fixation. Pathol Res Pract (1990) 0.95
Localization of Jacobsen syndrome breakpoints on a 40-Mb physical map of distal chromosome 11q. Genome Res (1999) 0.93
Submicroscopic deletions of 11q24-25 in individuals without Jacobsen syndrome: re-examination of the critical region by high-resolution array-CGH. Mol Cytogenet (2008) 0.93
Molecular characterization of an 11q interstitial deletion in a patient with the clinical features of Jacobsen syndrome. Am J Med Genet A (2006) 0.92
Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3). Am J Med Genet A (2008) 0.90
Deletion of JAM-C, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. Am J Med Genet A (2009) 0.85
Heart development in the spotted dolphin (Stenella attenuata). Anat Rec A Discov Mol Cell Evol Biol (2003) 0.81
Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell (2003) 8.00
A myocardial lineage derives from Tbx18 epicardial cells. Nature (2008) 6.15
De novo mutations in histone-modifying genes in congenital heart disease. Nature (2013) 5.15
Atenolol versus losartan in children and young adults with Marfan's syndrome. N Engl J Med (2014) 5.11
High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res (2009) 4.32
Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging (2010) 3.50
Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest (2002) 3.33
Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet (1993) 3.10
Extracellular matrix remodeling and organization in developing and diseased aortic valves. Circ Res (2006) 2.91
Islet 1 is expressed in distinct cardiovascular lineages, including pacemaker and coronary vascular cells. Dev Biol (2006) 2.81
Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75
Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation (2013) 2.66
A central role for Islet1 in sensory neuron development linking sensory and spinal gene regulatory programs. Nat Neurosci (2008) 2.36
Hypoplastic left heart syndrome is heritable. J Am Coll Cardiol (2007) 2.24
An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest (2008) 2.19
Bicuspid aortic valve is heritable. J Am Coll Cardiol (2004) 2.18
Hypoplastic left heart syndrome: current considerations and expectations. J Am Coll Cardiol (2012) 2.10
NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol (2003) 2.09
Isolation and sequence analysis of a full-length cDNA for human M creatine kinase. Biochem Biophys Res Commun (1986) 1.96
Hypoplastic left heart syndrome links to chromosomes 10q and 6q and is genetically related to bicuspid aortic valve. J Am Coll Cardiol (2009) 1.88
Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol (2003) 1.86
Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clin Cancer Res (2006) 1.82
Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation (1997) 1.81
Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies. Cardiovasc Res (2004) 1.80
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther (2003) 1.79
Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype. Circulation (2005) 1.77
Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol (2009) 1.74
Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases. Thromb Haemost (2003) 1.73
Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol (2007) 1.71
Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology (1992) 1.70
Polymorphic ventricular tachycardia and KCNJ2 mutations. Heart Rhythm (2004) 1.68
Transcription factors and congenital heart defects. Annu Rev Physiol (2006) 1.66
The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A (2004) 1.65
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
Correlation between abnormal cardiac physical examination and echocardiographic findings in neonates with Down syndrome. Am J Med Genet (2002) 1.61
Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation (1990) 1.61
The phenotypic spectrum of ZIC3 mutations includes isolated d-transposition of the great arteries and double outlet right ventricle. Am J Med Genet A (2013) 1.60
KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet (2002) 1.60
Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A (2004) 1.56
Risk factors for aortic valve disease in bicuspid aortic valve: a family-based study. Am J Med Genet A (2011) 1.55
Autonomous expression of c-myc in BC3H1 cells partially inhibits but does not prevent myogenic differentiation. Mol Cell Biol (1987) 1.52
Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation. Heart Rhythm (2012) 1.51
Analysis of cardiovascular phenotype and genotype-phenotype correlation in individuals with a JAG1 mutation and/or Alagille syndrome. Circulation (2002) 1.51
Human creatine kinase: isolation and sequence analysis of cDNA clones for the B subunit, development of subunit specific probes and determination of gene copy number. Biochem Biophys Res Commun (1987) 1.48
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation (2003) 1.45
Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet (2008) 1.43
A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ (2011) 1.42
Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet (2003) 1.42
A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest (2003) 1.41
Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol (2005) 1.41
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy. Neuromuscul Disord (2006) 1.40
Mouse heart valve structure and function: echocardiographic and morphometric analyses from the fetus through the aged adult. Am J Physiol Heart Circ Physiol (2008) 1.40
The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res (2013) 1.35
Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet (1992) 1.33
Magnetic resonance derived myocardial strain assessment using feature tracking. J Vis Exp (2011) 1.32
Mutation spectrum of MLL2 in a cohort of Kabuki syndrome patients. Orphanet J Rare Dis (2011) 1.32
Association between cardiac tumors and tuberous sclerosis in the fetus and neonate. Am J Cardiol (2003) 1.30
Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1. J Biol Chem (2007) 1.29
alpha-E-catenin inactivation disrupts the cardiomyocyte adherens junction, resulting in cardiomyopathy and susceptibility to wall rupture. Circulation (2006) 1.28
Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet (2007) 1.28
MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics (2011) 1.24
Fetal heart rate predictors of long QT syndrome. Circulation (2012) 1.24
Cumulative ligand activity of NODAL mutations and modifiers are linked to human heart defects and holoprosencephaly. Mol Genet Metab (2009) 1.21
Blimp1: a conserved transcriptional repressor critical for differentiation of many tissues. Exp Cell Res (2008) 1.20
MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J Mol Cell Cardiol (2012) 1.20
Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology (1992) 1.20
A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun (1987) 1.18
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson (2013) 1.18
An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal. Proc Natl Acad Sci U S A (1987) 1.17
Jacobsen syndrome. Orphanet J Rare Dis (2009) 1.14
Aortic root dilation in patients with 22q11.2 deletion syndrome. Am J Med Genet A (2009) 1.14
Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy. Am Heart J (2013) 1.14
Analysis of Ellis van Creveld syndrome gene products: implications for cardiovascular development and disease. Hum Mol Genet (2009) 1.13
Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg (2004) 1.12
Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia. Heart Rhythm (2011) 1.11
Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome. Circ Arrhythm Electrophysiol (2013) 1.11
Functional classification of pulmonary hypertension in children: Report from the PVRI pediatric taskforce, Panama 2011. Pulm Circ (2011) 1.11
Prenatal head growth and white matter injury in hypoplastic left heart syndrome. Pediatr Res (2008) 1.09
Quantifying pulmonary regurgitation and right ventricular function in surgically repaired tetralogy of Fallot: a comparative analysis of echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging (2012) 1.09
Identification, tissue-specific expression, and subcellular localization of the 80- and 71-kDa forms of myotonic dystrophy kinase protein. J Biol Chem (1995) 1.08
Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. Circulation (2011) 1.06
Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine (2010) 1.06
The 22q11.2 deletion in African-American patients: an underdiagnosed population? Am J Med Genet A (2005) 1.05
Jagged1 (JAG1) mutations in patients with tetralogy of Fallot or pulmonic stenosis. Hum Mutat (2010) 1.05
Late effects in survivors of tandem peripheral blood stem cell transplant for high-risk neuroblastoma. Pediatr Blood Cancer (2008) 1.05
Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Hum Mutat (2011) 1.05
TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion. Am J Med Genet A (2014) 1.04
Detection of a new mutation in the beta-myosin heavy chain gene in an individual with hypertrophic cardiomyopathy. J Clin Invest (1992) 1.03
Elastin haploinsufficiency results in progressive aortic valve malformation and latent valve disease in a mouse model. Circ Res (2010) 1.02
Variants of folate metabolism genes and risk of left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol (2010) 1.02
MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med (2011) 1.01